Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth

Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growthNovel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth, Published online: 19 February 2018; doi:10.1038/s41388-017-0076-0Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth

Source: Oncogene - February 19, 2018 Category: Cancer & Oncology Authors: Xia Li Hongguang Ma Lin Li Yifan Chen Xiao Sun Zizheng Dong Jing-Yuan Liu Weiming Zhu Jian-Ting Zhang Source Type: research